Entero Therapeutics Q3 EPS $(0.64) Up From $(1.77) YoY

Entero Therapeutics (NASDAQ:ENTO) reported quarterly losses of $(0.64) per share. This is a 63.84 percent increase over losses of $(1.77) per share from the same period last year.